Join us for a high-level panel discussion
on the role of precision diagnostics in
improving cancer care across Europe.
Integrated and Standardized NGS Workflows for Personalised Therapy
Recent Posts
- CEN Technical Specifications for NGS Workflows now under development in ISO
- Conference Announcement: Tackling the implementation gap for the uptake of NGS, 6th Sept. 2024 in Florence
- Award of Phase 3 Contracts
- Event Announcement: NGS for Precision Medicine and Pharmacogenomics in Cancer
- Call for Service Provision on "Advancing Personalised Oncology"
Important Events & Dates:
Deadline for Submission of Phase 3 Deliverables – 15th of April 2025
View information
Deadline for Submission of Phase 2 Deliverables – 15th of January 2024
View information
Deadline for Submission of Phase 1 Deliverables – 15th of August 2022
View information
Prior Information Notice (PIN) published on 28.12.2020
Download PDF Lot Information
Open Market Consultation (OMC)
View Partnering Platform
Request for Tenders – published on the 19th of October 2021
View Request for Tenders
Tendering Webinar 3rd November 2021 15:00-17:00 CET
View recording
Deadline for Tenders´ Receipt – 19th of December 2021
A Pre-Procurement Project for improving cancer patients’ benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmocogenetics testing and e-medication in proper presentation to medical doctors for supporting therapy decision making at bedside.
This 65 month H2020 project started in January 2020.
The maximum Grant Agreement amount is €10.998.128,16
Cofunded by the European Union under Grant Agreement No. 874719